Evidence map›Paper›PMID 30795580›Full record

ReviewJournal of fungi (Basel, Switzerland)2019

Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in

Jehoshua Sharma, Sierra Rosiana, Iqra Razzaq, Rebecca S Shapiro

Open access · goldAbstract readReview
In one paragraph

Review in Journal of fungi (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 64 citations in OpenAlex.

  1. A Cautionary Tale ofCase reports in veterinary medicine · 2026
    Article
  2. Article
  3. The Prevalence and Drug Susceptibility ofAntibiotics (Basel, Switzerland) · 2025
    Article
  4. A Comprehensive Overview ofJournal of fungi (Basel, Switzerland) · 2025
    Review
  5. Acridine Derivatives as Antifungal and Antivirulence Agents AgainstInternational journal of molecular sciences · 2025
    Article
  6. Article
  7. Article
  8. Characterization of OralAntibiotics (Basel, Switzerland) · 2023
    Article
  9. Article
  10. LC-MS Analysis and Antifungal Activity ofPlants (Basel, Switzerland) · 2023
    Article
  11. Article
  12. Metabolic Plasticity ofJournal of fungi (Basel, Switzerland) · 2022
    Article
  13. Antifungal Susceptibility ofAntibiotics (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Article
  16. Isoflavaspidic Acid PB Extracted fromBioMed research international · 2022
    Article
  17. Evaluation of the biofilm life cycle betweenFrontiers in cellular and infection microbiology · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jehoshua SharmaDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, ON N1G 2W1, Canada. jehoshua@uoguelph.ca.ORCID 0000-0002-6229-5153
Sierra RosianaDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, ON N1G 2W1, Canada. srosiana@uoguelph.ca.
Iqra RazzaqDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, ON N1G 2W1, Canada. irazzaq@uoguelph.ca.
Rebecca S ShapiroDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, ON N1G 2W1, Canada. shapiror@uoguelph.ca.ORCID 0000-0002-7119-8865
University of Guelph · CA

Funding

Banting Research Foundation 2018Canadian Institutes of Health Research 201803PJ3-404013
6 · The paper itself

Abstract

Fungal infections are a growing public health concern, and an increasingly important cause of human mortality, with

Indexed as

Antifungal drug resistanceAntifungal drugsCandidaFungal morphogenesisFungal pathogens

Identifiers

PMID30795580
PMCPMC6463059
OpenAlexW2916687671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.